| Pronunciation |
 (kan
THAR e
din) |
 |
| U.S. Brand Names |
| Verr-Canth™ |
|
| Generic Available |
|
No |
|
| Pharmacological Index |
|
Keratolytic Agent |
|
| Use |
|
Removal of ordinary and periungual warts |
|
| Pregnancy Risk Factor |
|
C |
|
| Contraindications |
|
Hypersensitivity to cantharidin |
|
| Adverse Reactions |
|
1% to 10%: Central nervous system: Delirium, ataxia Dermatologic: Dermal irritation, dermal burns, acantholysis Gastrointestinal: GI hemorrhage, rectal bleeding, dysphagia Genitourinary: Priapism Hepatic: Fatty degeneration Neuromuscular & skeletal: Hyper-reflexia Ocular: Conjunctivitis, iritis, keratitis Renal: Proteinuria, hematuria Respiratory: Burning of oropharynx |
|
| Usual Dosage |
|
Apply directly to lesion, cover with nonporous tape, remove tape in 24 hours, reapply if necessary |
|
| Mental Health: Effects on Mental Status |
|
May cause delirium |
|
| Mental Health: Effects on Psychiatric Treatment |
|
None reported |
|
| Dental Health: Local Anesthetic/Vasoconstrictor Precautions |
|
No information available to require special precautions |
|
| Dental Health: Effects on Dental Treatment |
|
No effects or complications reported |
|
| Patient Information |
|
Applying to open tissue will result in stinging; after 3 days may bathe and replace dressing; use only as directed by physician |
|
| Dosage Forms |
|
Liquid: 0.7% in a film-forming vehicle containing acetone, pyroxylin, castor oil and camphor (7.5 mL) |
|
|
|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
